Abstract
<b>Well-designed multicentre clinical trials are warranted to determine a safe and efficacious treatment regimen for patients with acute exacerbation of IPF and fibrotic lung disease beyond IPF</b>http://bit.ly/3KnaHtV
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
